The authors reviewed more than 50 studies of qigong therapy for cancer in China, in 3 categories: clinical studies on cancer patients, in vitro studies on laboratory-prepared cancer cells, and in vivo studies on cancer-infected animals. Most of the clinical studies involved observation of cancer patients' self-practice of qigong. Although no double-blind clinical trials were found among patient studies, many had a control. The qigong groups showed more improvement or had a better survival rate than conventional methods alone. In vitro studies report the inhibitory effect of qi emission on cancer growth, and in vivo studies find that qigong-treated groups have significantly reduced tumor growth or longer survival among cancer-infected animals. However, there is much room for improvement in these studies, and some require replication to verify the findings. Qigong therapy is an area that is often neglected by mainstream medicine and research, but our review strongly suggests that qigong deserves further study as a supplement to conventional cancer treatment.
Introduction
Qigong (pronounced "che gông") is a general term for a large variety of traditional Chinese energy exercises and therapies. There is no consistent definition for qigong in the academic field due to its broad coverage. Generally, qigong is considered to be the selftraining method or process through qi (vital energy) and yi (consciousness or intention) cultivation to achieve the optimal state of both body and mind. 1 Traditional Chinese medicine (TCM) posits the existence of a subtle energy (qi) circulating throughout the entire human body. When strengthened or balanced, it can improve health and ward off or slow the progress of disease. TCM considers sickness or pain a result of qi blockage or unbalanced qi energy in the body. All TCM therapies-herbs, acupuncture, massage, diet, and qigong-are based on this philosophy and perspective on human health.
It is generally known that qigong practice is beneficial to human health and can prevent disease. However, it is less known, even in China, that qigong may be an effective way to treat various diseases, including cancer. It is very common for people with no qigong experience to consider all qigong the same. In fact, there are thousands of different forms of qigong in China, and most of them were designed not to heal existing diseases but, rather, to be used as a prophylactic and/or a meditative exercise. Although most qigong styles bring health benefits, medical qigong is a small, specialized area of qigong that has been specifically developed for the treatment and cure of disease.
Medical qigong refers to the qigong forms used by TCM practitioners with emphasis on using vital energy (qi) to diagnose and take control of or eliminate illnesses, as well as prevent their onset. Qigong is mainly a self-training method that includes qi emission or external qigong therapy (EQT). EQT has always been part of the medical qigong practice as an element in the effort to help others regain their health. There are also differences between internal qigong training and EQT in the history and development of medical qigong. Internal qigong training refers to qigong practice or cultivation by oneself to achieve optimal health for both mind and body. This is a major component in medical qigong practice. EQT refers to the process by which a qigong practitioner directs his intention, or emits his qi energy, to help others break qi blockages and induce the sick qi to leave the body so as to alleviate pain, abate disease, and balance the flow of qi. Most research on qigong therapy for cancer patients has involved teaching patients to practice qigong (internal qigong training), whereas most research on qigong therapy for cancer in animals or culture cells has involved EQT.
Qigong and Cancer Treatment
Although there might be some cases of cancer recovery reported in many qigong forms, most qigong schools or clinics in China generally do not openly take patients with cancer due to their high mortality rate. For example, it has been reported that the largest medical qigong facility in China-Huaxia Zhi-Neng Qigong Center-has chosen not to admit any more patients with cancer after a cancer patient died in their facility. However, 2 qigong forms in China have publicly challenged cancer: Guo-Lin New Qigong and Chinese Taiji Five-Element Qigong.
A late-stage cancer patient, Guo Lin, who attributes her recovery from cancer to her practice of qigong in the 1970s, created Guo-Lin New Qigong. Guo started to teach this form of qigong to a number of cancer patients around the country. It has been said that many of them achieved complete remission from cancer after practicing Guo-Lin qigong. However, most practitioners of Guo-Lin qigong have used qigong mainly as a supplementary therapy to conventional treatments or other therapies. 2 Therefore, its therapeutic efficacy has not been sufficiently established as a stand-alone therapy, and it has not been fully recognized by Western medical doctors.
Taiji Five-Element Qigong was founded by Binhui He in response to the fact that modern medicine failed to provide a cure for many chronic diseases, and that many of the drugs used to treat these diseases have negative long-term side effects. The Chinese Society of Qigong Science appointed He as the director of the Qigong Anti-Cancer Research Center in 1993 after discovering from media reports that late-stage cancer patients had recovered completely by practicing this form of qigong alone without any other therapy. He then started formal clinical exploration of qigong anticancer therapy in his qigong training center. Many patients with late-stage cancer (most of whom were turned away by hospitals due to the lack of any existent medical treatment available at such a late stage) participated in He's intensive medical qigong training. Most of these patients achieved significant short-term improvement in their health and/or a recovery from cancer through qigong practice alone. Furthermore, a large proportion of these patients became cancerfree in the last 5 to 9 years. 3, 4 In an official assessment meeting held in 1996 by the Chinese government, Chinese scholars and experts in medicine and science examined a number of cancer cases and the results of scientific research with Taiji Five-Element Qigong. They affirmed the positive effect of the five-element qigong and concluded in their evaluation that it was "an effective way to treat cancer." [5] [6] [7] Research on Qigong Therapy for Cancer Media reports on cancer recovery by qigong have caught the attention of many scientists in China. Can qigong practice really have a therapeutic effect on cancer? It is well known that some cancer patients may experience spontaneous remissions without any therapy. How do we discern spontaneous remissions from qigong-induced remissions? Does qigong treatment provide merely a placebo, or does it truly provide a therapeutic effect?
Due to considerations of psychological effects and other limitations, most systematic research on qigong therapy for cancer has been focused on in vitro study of different cancer cells or in vivo study where cancer cells were injected into a live animal to observe the inhibitory effect of qigong therapy. Most clinical studies of patients have been case observations by medical professionals; no double-blind clinical trials could be found in the literature. In an attempt to understand how qigong therapy affects cancer treatment, this study reviewed more than 50 research studies (excluding case reports) that have a focus on qigong therapy for treating cancer. All of these studies were performed in the past 20 years and were published in China. These studies fall into 3 different categories: clinical study on human cancer patients, in vitro study of cancer cells with EQT, and in vivo (animal) study of cancer cells with EQT. It is hoped that such a review will interest more scientists in this ancient therapy and that, as a result, more well-designed research on the therapeutic effect of qigong therapy for cancer and other chronic diseases will be implemented.
Methods
This preliminary review uses 2 major sources of literature: (1) the Qigong Database of the Qigong Institute, 8 which has more than 1600 abstracts and papers from various conference proceedings and publications; and (2) the accessible publications in Chinese, including some conference proceedings in Chinese. Although there is no academic journal devoted specifically to qigong research, there are many collected research works (edited volumes), as well as specific magazines and journals, that publish qigongrelated research studies. Most of this literature has never been published in English.
Although there are numerous publications on qigong and cancer in Chinese, few truly adhere to Western academic standards with regard to research design and reporting format. Some were not written for academic exchanges or documentation. Consequently, incomplete data reports were a problem in this review. To fully take advantage of the published literature for future research in this area, we used the following 3 criteria for selecting studies to be included in this review: (1) it must be a research study with systematic data collection for the purpose of understanding the clinical improvement or significant differences between a qigong and a nonqigong group, not mean age of 47 years, 60 were men and 63 women; all were diagnosed pathologically with malignant tumor, 70 in stage III and 53 in stage IV. The qigong group (n = 97) was treated with conventional drugs plus qigong exercise (2 hours daily for 3 months), whereas the control group (n = 30) was treated with the same drugs alone. At the end of the treatment, the researchers found that among the qigong-plus-drug group, 82% regained strength, 63% improved appetite, and 33% were free of diarrhea or irregular defecation, whereas the rates for control group were 10%, 10%, and 6%, respectively (P < .01). They also found that 50.5% in the qigong group gained 3+ kg in body weight as compared to 13.3% in the control group; only 5.4% in the qigong group lost 3+ kg whereas 30% lost weight in the control group (P < .01). The blood tests of the 2 groups indicated that in the qigong-treated group, the mean phagocytic rate of macrophages increased from the previously tested result of 34.7% ± 8.9% to 47.0% ± 8.2% after the treatment (a 35% increase); the phagocytic indices were 0.45 ± 0.11 and 0.63 ± 0.13, respectively, before and after the therapy. The mean phagocytic rate in the control group did not elevate, but decreased by 7.8%; the phagocytic indices changed from 0.63 ± 0.18 before therapy to 0.50 ± 0.14 after therapy. In addition, 24% of patients in the qigong group had normal erythrocyte sedimentation and 21% had normal hepatic function; however, those with normal sedimentation and hepatic function constituted only 10% and 6.7% in the control group, respectively. In sum, the results suggest that qigong therapy has some beneficial effect in ameliorating the symptoms, improving the appetite, strengthening the constitution, and increasing self-healing ability.
Fu et al 12 of Henan Medical University observed 186 postsurgery patients of cardiac adenocarcinoma (155 men and 31 women; mean age = 59.8 ± 8.8 years) over a period of 3 years. Among them, 7.5% were in stage I, 24.7% in stage II, and 67.8% in stage III of various cardiac adenocarcinoma; 44.5% had lymph metastasis. The patients were randomly assigned into 4 treatment groups: surgery only (control; n = 48), chemotherapy only (n = 42), Chinese herbal therapy only (n = 46), and qigong plus herb therapy (n = 50). This last required the patients to practice specific qigong every day for a specific period of time. The postsurgery chemotherapy was the standard etoposide, doxorubicin and cisplatin (EAP) protocol, 2 courses in the first year, 2 courses in the second year, and 1 course in the third year. After more than 5 years of follow-up study, Fu et (2) and qigong + chemo groups (3) . Compared the level of RBC, WBC, serum hemoglobin and TAfter 60 days group 1 had a significant rise in WBC, RBC and serum hemoglobin after treatment (P < .01), while group 2 had significant lowering (P < .01). Group 3 had elevation of serum 43.5%, and 26.1%; and for the qigong-plus-herb group were 86.0%, 64.0%, and 36.0%, respectively. The differences between the qigong-plus-herb group and the control group were statistically significant (P < .01) (Figure 1 ). The median survival period was 30 months for the control group, 36 and 36.5 months for chemotherapy and herbal groups, and 48 months for qigong-plus-herb group. Unfortunately, the herbs and their combination were not specified in the report. Zheng et al 13 of the Shanghai Qigong Institute applied a comprehensive qigong therapy (qigong technique not specified) to 100 various late-stage cancer patients and compared their survival rate with those who had other therapies but no qigong therapy in the same hospital. They found that 1-and 5-year survival rates were 83% and 17% for lung cancer patients (the control was 7% in 5 years) and 83% and 23% for stomach cancer patients (the control was 12% in 5 years). The median survival period for liver cancer patients was 20.7 months in qigong group compared to with 3.5 months in the control group (P < .01). Huang 5 reports that a study at Jiangxi Medical School also applied qigong with conventional therapy to 20 cancer patients and reported much better 3-and 5-year survival rates among these patients (80% and 45%) compared to the average of similar patients in that hospital (65% and 34%).
Ye et al 14 of the Shanghai Qigong Institute studied the effect of qigong exercise on unscheduled DNA synthesis (UDS) of peripheral blood lymphocytes in a clinical trial of 65 various cancer patients, plus a normal control. The cancer patients were randomly assigned into either qigong (n = 33) or chemotherapy (control) group (n = 32) after surgery. After baseline measures were taken, the qigong group practiced Guo-Lin qigong for 3 months before the follow-up measurements were taken. Table 3 presents the results of UDS rates before and after the treatment. The qigong group had significant improvement in their DNA repair rate (P < .001), whereas the control (chemo) group had no change. Although both cancer groups had a lower UDS rate than a normal group, the UDS rate of the qigong group was significantly higher than that of the control group after the 3-month treatment period (P < .01).
Luo et al 15 of the Zhejiang Institute of TCM conducted a clinical trial with 80 cancer patients who were at stage I or stage II of the disease and who had previously received radiation or chemotherapy. The patients were randomly assigned to qigong (n = 30), chemo (n = 25), or qigong-plus-chemo (n = 25) groups. The counts of red blood cells (RBCs), white blood cells (WBCs), serum hemoglobin and T-lymphocytes were measured pre-and posttreatment. Vital gate qigong was used in this study. After 60 days of treatment, only the qigong group had a significant rise in WBCs, RBCs, and serum hemoglobin (P < .01), whereas the results of the control group were significantly reduced (P < .01). In the qigong-plus-chemo group, the patients had an elevation in serum hemoglobin, RBCs, and platelet count (P < .01), but WBC levels remained the same. A similar finding was reported by Wang et al 16 in their trial of 60 late-stage cancer patients: 29 of the 32 patients in the chemoplus-qigong group had improved health and a stable WBC count, whereas 12 of 30 patients in the chemoonly group reported worse health with more symptoms, and all controls reported a decline in WBCs (less than 4 × 10 9 /L) (P < .05). At the Teaching Hospital of Nanjing College of TCM, Wang 17 explored the antitumor mechanism of qigong therapy in a study of 104 different cancer patients (mainly comprising esophageal, stomach, rectal, and lung cancer). These patients were taught to practice qigong during their inpatient care, and continued doing so after surgery and leaving the hospital. The duration of qigong practice ranged from 6 to 24 Table 4 . The study showed that the proteins (AAT and AAG) dropped dramatically after qigong (P < .01) but that CER increased after qigong treatment (P > .05).
As to immune indicators, LAI decreased (P < .01) whereas ANAE increased after qigong practice (P < .05). In general, the qigong practice improved the cancer patients' immune function toward the direction of normal levels. Xu and colleagues 18 at the Jiangsu Provincial Institute of TCM conducted a series of studies to explore the mechanism of qigong antitumor therapy. In one of the studies, subjects were divided into 5 groups: (1) healthy people using qigong (n = 72), (2) healthy people not using qigong (n = 50), (3) beekeepers (n = 50), (4) cancer patients using qigong (n = 50), and (5) cancer patients not using qigong. All of the malignant tumors were identified and confirmed by pathological biopsy. A blood sample was drawn from each person to test his or her T-lymphocyte level by ANAE staining. The ANAE determination (x ± SD) in the first group was 74.9% ± 11.6% versus 65.6% ± 8.9% in the second group (P < .01), and in the fourth group was 69.2% ± 12.8% versus 42.8% ± 7.1% for the fifth group (P < .01). The third group (a special control group) was 76.8% ± 11.1%. The people who had practiced qigong (whether they were healthy or a cancer patient) had significantly higher levels of ANAE than those who did not. In another study, Xu et al 19 measured the copperzinc superoxide dismutase (Cu-Zn SOD) activities in RBCs among 229 cancer patients (124 in qigong, 105 in control group) by color immunological plate reaction to the enzyme. They reported that qigong practice raised the Cu-Zn SOD activity: after practicing qigong, the Cu-Zn SOD activity in RBCs is 399.758 ± .3 µg/gHb versus 356.82 ± 2.3 µg/gHb without practicing qigong (P < .001).
Recently, Cai et al 20 of Shanghai Fangyi Hospital reported changes in the immune indicators and physical health among 1883 cancer patients after practicing Guo-Lin qigong. After practicing Guo-Lin qigong for 2 months, a blood sample was drawn from each patient; the RBC and WBC count, immune protein IgG, IgA, and IgM levels, natural killer (NK) cells, and different cluster designation (CD) cell counts were measured. Cai et al reported that most patients showed remarkable improvements in these categories and that their immunity levels were raised after qigong practice, especially WBC, CD20, interleukin-2 (IL-2), and NK activities (P < .01). In addition, 40.8% patients reported improvement in sleep and 36.8% reported improvement in appetite.
Among the clinical studies reviewed, although some lacked a valid control group, it seems that there is a consistent tendency that the group treated with qigong therapy in combination with conventional methods had more significant improvement and/or a better survival rate than the group treated with conventional methods alone. Some studies reported complete remission from late-stage cancer or metastasized cancer, which is considered an impossible result through the use of conventional medicine alone. More extensive reviews of in vitro and in vivo studies of qigong therapy for cancer may change our stereotype of this ancient energy therapy.
In Vitro Studies With EQT
To effectively exclude the potential psychological effect of qigong therapy in cancer treatment, scientists in China have paid special attention to the in vitro study of various cancer cells with the application of external qigong therapy in order to understand how qigong treats various cancers. The typical in vitro study has involved randomly dividing the laboratoryprepared cancer cells or other cultures into different groups with at least 1 group being treated with external qi by a qigong healer, plus 1 or 2 control groups. Sometimes, 1 group was treated by sham qigong (person without qigong training but simulating qigong movement) for the same amount of time. The cancer cells being studied varied tremendously, including human breast cancer (BC) cell lines, erythroleukemia (K562), promyelocytic leukemia, nasopharynglioma, nasopharyngeal carcinoma (CNE-2), SGC-7901 gas- tric adenocarcinoma, spleen cells of mice, lung tumor cell line (LA-795), and so on. Table 5 presents some major findings of these studies. Feng and colleagues [21] [22] [23] at the Chinese Immunology Research Center (Beijing) is one of the first research groups to conduct studies on the effects of the emitted qi by qigong on human carcinoma cells. They used the techniques of tissue culture, cytogenetics, and electron microscope to study the effect of external qi on HeLa cells and SGC-7901 human gastric adenocarcinoma cells. They repeated the same HeLa cell experiment 20 times under identical conditions (treatment sample exposed to external qi for 20 minutes) and found that the survival rate of the HeLa cells in the qigong cultures was on average 69.3% of that of control cultures; that is, 30.7% of the cells were killed in the 20-minute exposure to external qi. The electron microscope showed that degeneration and swelling took place in some of the cells exposed to emitted qi. The experiment with human gastric adenocarcinoma cells was repeated 41 times under the same condition (1-hour exposure to external qi by a qigong master), in which the average survival rate of the SGC-7901 cells was 74.9% of that of controls; that is, the average destruction rate was 25.02% (P < .01). The total abnormality rate of the chromosomes in the qigong cultures (5.39%) was significantly higher than that in the control cultures (1.40%).
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Chen and colleagues 24 of the Zhongshan University of Medicine have been involved in many studies in this area. In one of their studies, a qigong practitioner was invited to emit external qi toward the human CNE-2 cell line to observe the cell growth inhibition and (3H)-thymidine ([ 3 H]-TdR) incorporation inhibition. Compared to the nontreatment control, the inhibitory rates for CNE-2 growth in 4 separate qigong experiments were 43%, 33%, 60%, and 36% (P < .05) (Figure 2 ). The [ 3 H]-TdR incorporation inhibitory rates in 6 different experiments of external qi ranged from 22% to 53% (P < .01). Chen et al subsequently repeated this line of both in vitro and in vivo research and had similar findings. 25, 26 These data suggest that external qi can inhibit the cell growth and DNA synthesis of the CNE-2 cells. Cao et al 27 of the Cancer Institute at Sun Yat-Sen University of Medicine replicated Chen et al's findings on the inhibitory effect of EQT on CNE-2 growth. They compared the number of CNE-2 cells cloned after 3 types of treatment-EQT only, gamma (G) ray only, and EQ + G ray-and found that the number of cells cloned in the G ray + EQT cultures was 9.2 ± 2.5, significantly lower than the G ray cultures (15.8 ± 2.4; P < .001). The kinetic study showed that the number of cells cloned in the EQT cultures was 16.5 ± 2.2, close to the level of G ray cultures, but that it had started to increase after 48 hours, whereas the G ray cultures continued to decline after 48 to 96 hours of cultivation.
Guan et al 28 of the Guangzhou College of TCM used similar techniques-[
3 H]-TdR incorporation and tissue culture-to study the effect of EQT on the growth of human lymphocytes and tumor cells (erythroleukemia, K 562 ). They found that the same external qi had different effects on the 2 kinds of cells. The EQT promoted the growth of normal human lymphocytes (counts per minute [cpm] = 6032.4 4 ± 937.0 in the qigong-treated cultures and 3970.4 ± 3722.7 in the control cultures; P < .05) but inhibited the growth of K 562 cells (cpm = 9340.8 in the qigong group vs 10760.2 in the control group; P < .01). Yu et al 29 of the First Central Hospital of Tianjing also used [ 3 H]-TdR incorporation and tissue culture methods to study a malignant mouse lung tumor cell line (LA-795) and normal cells (L-929) in mice and found that the malignant cells were markedly destroyed or killed after exposure to EQT. Compared to the control group, the kill rates in 2 EQT groups (n = 6 each) are 26% ± 6.9% and 21% ± 8.5% (P < 0.01 in both studies), whereas the normal cells that had undergone the same treatment remained intact.
At the Shanghai Institute of TCM, Chen 30 studied the effect of EQT on the human liver cancer cell line (BEL-7402) and lung cancer cells (SPC-A1). Levels of adenosine triphosphate (ATP) and alpha-fetoprotein *Randomization not mentioned in most studies unless otherwise specified. NBM = no blinding mentioned.
(AFP) of the cancer cells were measured 24 hours after EQT (40 minutes in 2 treatments) to determine the activity of the cancer cell lines as compared to their activity after sham treatment. Compared to the shamtreated control group, the level of ATP in the EQT group increased significantly after EQT. Meanwhile, the AFP levels in the EQT group decreased. Repeated experiments confirmed similar results for EQT effect: AFP levels decreased. 32 Examination under the electron microscope found that compared to the sham control, the EQT group had some visible changes, such as increase in cytoplasmic vacuolation, some light points in the cytoplasm and the nucleus, cell membrane broke degeneration, disappearance of cell nucleus, and cell swelling and death. In general, the SPC-A1 in the EQT group lost the characteristics of a cancer cell. 30, 31 Recently, we conducted a pilot study to explore the effects of EQT on the expression of preprotachykinin-I (PPT-I, an immune/hematopoietic modulator gene) expression in 4 types of BC cells by inviting a Chinese qigong healer to work with us. In our study, 4 BC cell lines (BC-123, BC 125, BC-HT-20, and BC-T47D) were grown to confluence in four 6-well plates, 1 plate for each treatment condition: external qigong treatment, sham treatment, incubator control, and room temperature control. The Chinese qigong healer emitted qi directly to the cell culture plates for 10 minutes. The incubator control plate was kept in an incubator in the lab, and the room temperature plate was left on a lab bench in the same lab. The sham treatment was performed by an individual who had no training in qigong but, rather, imitated the movements of the qigong healer. After the designed treatment, all plates were reincubated for 16 hours. Total RNA was extracted by using the standard procedure and used in quantitative reverse transcriptasepolymerase chain reaction (RT-PCR) to determine the levels of β-PPT-I. The technician who did the extraction and counted the cell growth was blinded to the plate identity. The results showed no significant difference between the controls (the sham-treated, incubator, and room temperature plates). However, there was a consistent and obvious downward trend among the BC cells treated by qigong. Except for the BC-T47D cells, qigong-treated cells have a consistently lower cell growth rate than any other groups. Compared to sham-treated cells, the closest control in this design, in all 8 observations (4 different BC cells in 2 separate trials), the qigong-treated cells had the slowest growth. This could have occurred by chance only at P = .0038 in a cumulative binomial probability distribution. Figure 3 presents the result of 4 treatments for BC-HT-20 cells in 2 separate trials. Unfortunately, a follow-up study 5 months later with the same qigong healer did not replicate these results due to laboratory contamination.
Other similar in vitro studies of EQT on cancer cells include that of Cao et al 32 on the effect of EQT on IL-2, interferon-r (IFN-r), and lymphocyte transformation from spleen cells of C57BL mice; Hu et al 33 on the effect of EQT on human promyelocytic leukemia cell line (HL-60); and Ye et al 42 on EQT killing rate of human peripheral blood lymphocytes. Due to limitations in space, we will not discuss these in vitro studies in detail. In short, most of the published in vitro studies have used a design similar to that reported above, and demonstrated a significant inhibitory effect of external qigong on the growth of the studied cancer cells in comparison to control and sham-treated cells. This strongly suggests that the effect of qigong therapy for cancer is not purely psychological.
In Vivo Studies of Qigong Therapy for Cancer
The in vivo studies of qigong therapy for cancer treatment are more sophisticated and more closely resemble those of human application. The typical study of this type involved the injection of tumors or cancerous cells into mice or rats, then randomly dividing the experimental animals into various groups with 1 group being treated by qigong for a set period of time. The control group could be either nontreatment or sham treatment. The major results of these studies were concentrated on the survival rate of the animals themselves or the rate of tumor size reduction. The summary findings from 18 published in vivo studies are presented in Table 6 . In general, most studies reported that the qigong-treated group had significantly reduced tumor growth and/or longer survival lives among the cancer-infected animals. One of the largest studies of this type was conducted at Xuanwu Hospital of Capital Medical College by Zhao and colleagues, 35 who chose gliomas in mice (G 422 , a very stable and malignant tumor model) as the experimental model and conducted a total of 25 trials or studies. Each trial had a treatment and a control group. Zhao et al used 11 qigong healers, 2 nonqigong practitioners, and 494 mice with induced gliomas. In most trials, the mice were transplanted with gliomas before they were randomly assigned into either qigong treatment or a control group. The mice were sacrificed around 12 days after the transplantation in order to remove the tumors for various examinations. Among the 25 separate studies, they observed an inhibitory effect on the qigong group in 16 (64%). Of these, 11 had an inhibitory rate greater than 20% whereas 4 had an inhibitory rate greater than 40%. However, in 8 of the 25 studies, the qigong-treated group had a larger tumor than the nontreatment control, including 5 studies with qigong healers and 3 with nonqigong practitioners. The studies with increased tumor growth usually had a shorter period of time being exposed to external qi (3 to 10 minute a day instead of 60 minutes a day in other studies) and a different style of qigong (different healers or nonpractitioners). This result suggests that not all qigong can produce the same inhibitory effect on tumors and that the amount of time exposed to qigong may play a significant role in the healing (dosage effect).
Chen, Yeung
Using funds from the Chinese National Science Foundation, Li and colleagues 36 of the Xiyuan Hospital of the China Academy of TCM examined the effect of EQT on the gliomas in mice (G 422 ) treated with EQT. In their studies, tumor-implanted mice were divided into 4 groups: normal control, tumor control (no treatment), EQ 1 (once a day), and EQ 2 (once every other day). Eight different qigong healers emitted EQT to different mice 10 minutes daily or every other day. After 11 days of qigong treatment, mice were sacrificed in order to weigh the lymph nodes and spleens. Blood samples were obtained, lymphocyte suspensions were prepared, and the activities of NK cells and killer (K) cells were measured. Li et al found that the tumor growth in EQT groups was significantly slower than that in the control (P < .05); the NK cell and K cell activities in the normal control and the EQT groups were significantly higher than in the tumor control group (see Table 7 ).
Qian et al 37 examined the effect of external qi on cancer growth, metastasis, and survival time of the host. Tumor models were formed in 114 mice by transplantation of U27 or MO 4 cells into their subcutaneous tissues. The tumor-infected mice were randomly divided into 2 treatment groups for 3 separate studies: qigong group (exposed to external qi 10 to 30 minutes daily for a period of time) and control group (no treatment). In study 1, mice in both groups were sacrificed on day 20 after the transplantation. The average tumor volume in the qigong group was significantly lower than that in the control group (2.25 ± 5.35 vs 6.32 ± 10.02 cm 3 ; P < .001). In study 2, the mice were sacrificed on day 23 and all axillary lymph nodes and the lungs were taken out individually to be examined histopathologically for metastasis. The metastatic rate in the qigong group was significantly lower than that in the control group (1/16 vs 6/15; P < .05). In study 3, the mice were allowed to live out their lives and the time of death was recorded for each. The average survival time in the qigong groups (n = 10) was significantly longer than that in the control group (35.4 vs 30.5 days; P < .01). The same authors performed similar studies in different settings, and all reached the same conclusion. 38, 39 To explore the effect of external qigong emission on transplanted hepatic cancer in mice, Chen and colleagues 40 at the Zhongshan University of Medicine investigated the anticancer efficacy of external qi from a master of Chinese Taiji Five-Element Qigong on transplanted liver cancer in mice. Thirty mice that had been injected with hepatocarcinoma were randomly assigned to 3 groups: control (no treatment), sham (a nonqigong person imitating the qigong master's movement), or qigong (treated by a qigong master). The qigong treatment involved the qigong master emitting EQT toward the mice at a distance of 10 to 15 cm for 10 minutes from day 3 of transplantation, every other day, for a total of 4 sessions. The mice were then sacrificed on day 10 or 11. The liver cancer was separated out, measured, and weighed in a blind fashion. The results of 3 repeated experiments of this description are presented in Figure 4 . Compared to the control group, the tumor growth inhibitory rates of the qigong-treated group were 70.3%, 79.7%, and 78.7%, respectively (P < .0001). The inhibitory rates of the oma transplanted in mice 30 mice injected with hepatocarcinoma were randomly assigned in 3 groups: control, sham and real EQ. EQ group exposed to qi 10 mins a day for 4 days. Mice were sacrificed 72 hrs after treatment to isolated the tumor. Tumor growth inhibitory (TGI) rate was estimated in comparison with the tumor weight of control group. The same design was repeated 3 times. The TGI rates of EQ group were 70.3%, 79.7%, and 78.7% respectively (P < .0001) in 3 studies with the same design.
Qigong Therapy for Cancer in China
The TGI rates of sham group were 9.5%, 2.6%, and 2.5% respectively (P > .05). Electron microscopy showed the morphological changes in tumor cells among EQ groups:
decreased cell volume, nuclear condensation, nuclear fragmentation, decreased ratio of nucleus and cytoplasm.
The study won a national scientific research award in 1996.
Chu & Jiang 1989 44 88 Y C57BL mice with lung tumor After induction with urethane (1 mg/g of body weight), mice were randomly divided into 2 groups: control (48) and exp. group (40; exposed to qigong music for 2 hr/day, 6 day/week for 4 months). The tumor induction and mean tumor number were measured before and after treatment. The lung tumor induction: experimental group 87.5%, vs control group 100% (P < .05). The mean lung tumor number in the exp. group was 2.73 tumor cells into the right axillary region, and then divided randomly into CY group (injection of CY daily at 40mg/kg), control group, qigong only group (EQ twice a day), and CY + EQ group.
After EQ or CY treatment, the average tumor weight of EAC was 1.79g for control, but 0.91g for EQ, 0.47g for CY, and 0.35g for CY+EQ (P < .01). The tumor growth inhibitory rate of S-180 TBM was 65.7% for EQ group and 90.3% for CY+EQ (P < .01). The NK activity for EQ only is 17.4 ± 7.1; 20.1 ± 5.7 for CY+EQ, vs 8.4 ± 3.7% for control (P < .01). MTC activity for CY+EQ is 11.0 ± 5.6%, vs 23.1 ± 7.33% for control. IL-2 levels were 0.34 ± 0.03 vs 0.30 ± 0.02% for control (P < .01).
Medical school study published in academic journal. NBM Li et al 1990 36 24 + 29 Y Mice implanted with G-422 neuroglioma cells Tumor-implanted mice were divided into 4 groups: normal control, tumor control, EQ 1, and EQ 2. Eight different qigong healers emitted qi to different mice once a day. After 11 days of qigong treatment, mice were sacrificed to weigh the lymph-node and spleen. Blood samples obtained, lymphocytes suspension prepared, and activities of NK and K cells measured. The tumor growth in EQ groups was significant slower than control (P < .05). The NK cell activities in normal control, tumor control and EQ 1 + 2 groups were (x ± SD):
62. ? N Tumorerythrocyte rosette Mice of ICR strain were exposed to qigong field (group qigong lecture) for 7 days, and then analyzed for their body weight and tumor formation rate. Tumor cells were pretreated with fresh serum. A comparison of before and after the exposure.
After exposure to qi field, the tumor cells in mice were adhered by red cells, and the % of rosette-forming were increased from 5.67 ± 3.75 to 11.06 ± 5.25 in day 2, and to 27.8 ± 3.6 in day 7 (P < .01). The weights of the mice were reduced. The % of tumor cells not pretreated with serum Mice with MO 4 were randomly divided into the EQ and control group. Three experiments were done by injecting mice with the MO4 cells in all groups; the length of survival time was measured. In exp. 1 and 2, the volume of the intra-abdominal tumors were different between EQ and control group (P < .01), but the survival period and the volumes of the body ascites did not differ significantly. In exp. 3, the survival period and avg. tumor volume per day had a significant diff. between EQ and control (P = .02 for survival, P ; P < .001). In exp. 2, the metastatic rate of the lymph nodes in EQ group (1/16) was significantly lower than the control (6/15) (P < .05). In exp. 3, the avg. survival time (35.4 days) of mice in EQ group was longer than the control (30.5 days) (P = .002).
Qi may inhibit the tumor growth and prolong survival time. NBM
Qian et al 1998 39 31 Y U27 cancer in mice Mice with transplanted U27 cancer were divided into EQ and control group. EQ group received qigong 10-30 min. per day; and both groups were then autopsied for analysis on day 23 or day 33.
EQ group had only 1 lymph node metastasis (1/16), 2 lung metastasis (2/16), and the avg. tumor volume 1.82 cm 3 . In control group, 6 had lymph node metastasis (6/15) and 3 had lung metastasis (3/15), and the avg. tumor volume 6.75 cm 3 (P < .01).
NBM
Shao et al 1990 48 30 Y S180 sarcoma cells implanted into mice Light and electronic microscopy used to observe mice with implanted S180 sarcoma treated with qigong. Changes in the number of nucleolus organizing regions (NOR) in the sarcoma were investigated using the argyrophil (Ag-NOR) technique. In the EQ-treated mice sarcoma, the avg. diameters of cells and nuclei, the ratio of nucleus to cytoplasm and the number of tumor cells division phase and Ag-NOR counts in the nuclei all were much less than those in the control group (P < .001). 363 natural proliferation rate were observed. was lower than control (P < .025), but CY+ EQ group is higher than CY or control group (P < .001).
Zhao et al 1991 35 494 Y Gliomas of mice Mice induced with gliomas were divided randomly into EQ and control group. A total of 25 trials were run with 13 qigong masters applying their EQ to reduce the size of gliomata. The immune functions of mice were examined and compared. After applying EQ by 13 masters, 64% (16 groups, 160) of the mice shrank in gliomata size, but 32% (8 groups) actually had bigger gliomata than the control group. In EQ group the WBC count, lymphocyte count, the weight of spleen, and function of lymphocytes all had positive changes (statistically significant -see text for details). sham-treated group were 9.5%, 2.6%, and 2.5%, respectively (P > .05). Morphological alterations in qigong-treated mice include decreased cell volume of most cancer cells; nuclear condensation; nuclear fragmentation; decreased ratio of nucleus and cytoplasm; swollen mitochondria with poorly organized mitochondrial cristae, some vacuolated; and many apoptotic bodies in extracellular space. These results indicate that Chinese Taiji Five-Element Qigong inhibited the growth of transplanted hepatocarcinoma in mice.
In addition to the consideration of psychological effect in qigong therapy, a major problem in the previous qigong research has been reproducibility. Many qigong healers could not effectively repeat what they did in a prior study, which raised concern about the reliability, and sometimes the validity, of the effects or differences observed in qigong research. The Chen et al 40 study achieved very good stability and reproducibility. The 3 separate experiments showed very similar results, which demonstrated the inhibitory potential of qigong therapy on cancer.
Lei and colleagues 41 at Tongji Medical University examined the in vivo antitumor effect of EQT on the immunologic functions of tumor-bearing mice (TBM). They investigated the effects of both EQT and cyclophosphamide (CY) on splenic NK activities, macrophage-mediated tumor cytolysis (MTC) activity, and IL-2 production level of different groups of TBM. The TBM inoculated with Ehrlich ascites tumor (EAC) or sarcoma-180 (S-180) were randomly divided into 4 groups: tumor control, qigong only, CY only, and CY plus qigong. The qigong group was exposed to EQT twice a day for 2 weeks, and the CY group was injected with CY daily at 40 mg/kg. The results show that EQT had significant tumor growth inhibition rate in both models ( Table 8 ). The NK activity was 17.4% ± 7.1% for EQT only, 20.1% ± 5.7% for CY plus EQT, and 8.4% ± 3.7% for control (P < .01). The MTC activity for CY plus EQ was 11.0% ± 5.6% versus 23.1% ± 7.3% for control (P < .01). IL-2 levels were 0.34% ± 0.03% for EQT versus 0.30% ± 0.02% for control (P < .01).
A similar in vivo study of the effects of EQT and chemotherapy on antitumor lymphokines was done by Zhang et al 42 at the Beijing College of TCM. In this study, CY-induced immunosuppressed mice were randomly divided into CY, CY + EQT, and control groups. The CY + EQT group received qigong for 20 minutes a day for 8 days. Splenocyte suspensions (5 × 10 6 /mL) were then made into several parallel portions for inducing IL-2, IFN-r, and lymphocyte transformation. After the treatment, the thymus index of the CY group was 2.30 ± 0.42, of the control group was 3.91 ± 0.57, and of the CY + EQT group was 2.97 ± 0.54. The splenocyte spontaneous proliferation rate in the control and CY groups was low (3062.5 and 3294.0, respectively), but the CY + EQT group was as high as 7261.7 (P < .05). IL-2 activity of the CY group was lower than that of the control group (P < .025), but of the CY + EQT group was higher than that of the CY and control groups (P < .001).
There are many similar in vivo studies in the literature. tumor model in mice in 3 separate trials. All were welldesigned in vivo studies with valid controls, and each reported a significant inhibitory effect or prolonged survival time from EQT among tumor-bearing mice.
Discussion and Conclusion
Cancer is the second leading cause of death in the United States. Half of all men and one third of all women in the United States will develop cancer during their lifetimes. Most current treatments for cancer are effective in controlling the symptoms or prolonging patients' lives to varying degrees, but all come with significant drawbacks, including toxicity, costs, and potential harm to both mental and immune function. Therefore, an effective nonpharmacological therapy for cancer with less cost and no side effects could have a major impact on cancer treatment. Qigong therapy from TCM shows promise in treating cancer, and preliminary studies report immediate improvement without side effects, even recording complete remission in patients who engaged in ongoing practice of qigong. 7, 49 This form of medicine involving energy has the potential to become a powerful alternative to, or complementary therapy for, the conventional treatment of cancer. However, there is a need for betterdesigned clinical trials that systematically apply this therapy in human patients to determine its efficacy and applicability so that more people can benefit from it.
It is true that there is room for improvement in these preliminary studies, and the studies in general need to be replicated by more laboratories and clinics in order to verify their findings. Nonetheless, it is not hard to draw a general picture that qigong therapy for cancer treatment deserves further study. Unfortunately, this is an area that is often neglected by mainstream medicine and research. A deeper understanding of this mode of therapy is required for it to become more widely accepted in the medical community.
Possible Mechanisms
Most of the studies we reviewed have simply attempted to prove a principle: that qigong therapy for cancer could be effective, and that it is more than just a psychological effect. This is an important first step to get more research scientists interested in this area. However, some studies have also offered scientific explanation for the results that touch on some of the mechanisms of qigong therapy for cancer. We are planning a separate review specifically on this topic, especially on how qigong therapy might affect the human immune system. The following is an outline of the major scientific findings on the possible mechanisms of qigong therapy for cancer.
Qigong therapy may improve immune functions.
The human body has a powerful immune system, but most cancer patients experience some form of immune deficiency that makes it possible for cancer cells to outlive normal cells, and that leads to numerous clinical problems and reduces quality of life. Many research studies suggest that qigong therapy and/or qigong practice may help cancer patients improve their immune function. For example, Feng et al 22 found that external qi from the qigong healer could enhance the phagocytosis of peritoneal macrophages and increase the activity of acid phosphatase. From their clinical studies of cancer patients, Zhang 9 reported that qigong practice significantly increased cancer patients' C 3 b rate of red blood cells, the rate of lymphocyte transformation, and phagocytosis. Studies showed that increases in NK cells and many other components of the immune system can significantly reduce the chances of infection or tumor growth. 20, 23 Some studies also reported the rise in the level of T lymphocytes with enhanced immune function after qigong. 17, 18, 50, 51 Other components of the immune system, such as the activity of macrophages and bactericidal functions of neutrophils, also improved as the patients practiced qigong and/or received qi from a qigong master. 52 Given the fact that most conventional cancer therapies tend to damage or destroy the patient's immune functions, which in turn reduces overall capability of self-recovery, the indication of improvement in the immune system from qigong therapy warrants further in-depth research. between microartery and microvein (capillary). Qigong practice has been reported to improve the practitioner's microcirculation, changing the viscosity of blood, increasing elasticity of blood vessels, and controlling the concentration of platelet. One study in this area measured the skin temperature before and during qigong practice and found an increase in back surface temperature and greater infrared radiation from the palm. 53 Another study reported significant increase in microcirculation of nail wrinkles among 19 subjects, from a mean of 8.2 lines/mm prior to qigong to 12.6 lines/mm after qigong (P < .001). 53 It was concluded that qigong therapy could adjust the microcirculation function to an optimal state by accelerating blood flow, raising the skin temperature, and increasing the number of micro blood vessels, which in turn increases the oxygen and blood supplies to the tissues and cells, strengthens the metabolism, and changes the pathological state to a normal physiological state to achieve the antitumor effect or maximize the efficacy of chemotherapy. Huang 2 also reported increased microcirculation of lung among cancer patients who practiced Guo-Lin qigong.
Qigong therapy may raise the pain threshold. In the early 1980s, psychologists in China started to explore the possibility of qigong therapy raising the pain threshold, and they achieved some positive findings. For example, Wang et al 54 at the China Academy of Science tested the pain threshold of different locations on the body among 59 cancer patients and found that the pain threshold at the right inner joint increased from 122.2 g before to 164.07 g during qigong practice (P < .01) and the pain threshold at the left inner joint increased from 100.0 g to 125.76 g during qigong practice. Zhang and colleagues 55 at Zhong Shan Medical University also reported the analgesic effect of external qi in a placebo-controlled study and found that EQT could increase human skin pain threshold, measured by the method of potassium-mediated pain. Yang et al 56 reported the analgesic effect of emitted qi on rats, decreasing the probability of a purely psychological effect on pain.
Many other explanations with regard to the interaction between the qi (vital energy) and the physical body have not been completely verified by research. Qigong's therapeutic properties may also lie in its regulation of the respiratory system, the metabolic system, activity of the cerebral cortex, the central nervous system, and the cardiovascular system, as well as its effect in correcting abnormal reactions of the organs, the massaging effect on the organs of the abdominal cavity, and its effect on self-control over the physical functions of one's body. 51 There is not yet enough research or data to sufficiently document these effects. According to TCM, qigong may work to benefit the practitioners through 3 different channels. (1) Increased qi flow strikes against the location of illness such as a tumor. According to TCM, good health is the result of a free-flowing, well-balanced qi (energy) system, whereas sickness and pain are the results of qi blockage or unbalanced energy in certain areas of the body. Once the supply of qi to the cells becomes blocked, blood flow to that area will change, the cells or related organs might start to malfunction, and disease or pain may occur. One possible mechanism of qigong therapy for pain relief and symptom reduction is through motivating qi and energy within the body, breaking the qi blockage, and balancing the energy system. From a research perspective, the in vitro studies suggest that qi energy may have a direct inhibitory effect on tumor growth, or even kill cancer cells. (2) Cultivation of Yi (consciousness and intention) and the emphasis of "empty mind without desire" in qigong practice may help the practitioners to strengthen the power of their intention and to release suppressed emotions and/or mental disturbances. It is said that qigong training of the mind (or intention) helps practitioners to release themselves from the "socialized self " (the source of all stress) and return them to the "original self." The source of cancers could be related to some mental/emotional disturbances and social pressures (such as ongoing stress) that over time lead to a malfunction of the immune system. Qigong practice may lead to the release of these mental/emotional disturbances or twists, which may be the real source of the cancer in the first place. This may also help patients tolerate the ongoing stress related to their disease or its conventional treatments. (3) Qigong may rapidly reveal or uncover the body's potential self-healing capability, including the increased immune functions (as described above), the self-repair capability, and the self-regeneration capability. For example, the relaxed and tranquil state achieved during qigong practice can relieve stress, build up vital energy, and rapidly increase the body's immune function. We have observed some patients of qigong therapy who have completely recovered from multiple, complicated diseases or symptoms in a short period of time without any medications. There are reports of regenerated lost physical parts, such as new hair growth and new tooth growth among adults and seniors. In this sense, qigong therapy has challenged the current medical practice's tendency to depend on the use of pharmaceutical drugs that treat a specific symptom only with many known and unknown side effects.
Problems and Limitations
Although qigong may be one of the most powerful alternatives for traditional Western medicine and therapy on cancer treatment, current research geared toward qigong and its therapeutic effect may have many deficiencies and limitations. To recognize these problems is a necessary step of more in-depth investigation into qigong therapy.
Lack of a sophisticated research design and compatible control groups undermines the results of many clinical studies. Observational studies are a good first step to interest more doctors and scientists to focus on this therapy, but they are not enough to determine the actual effectiveness of qigong therapy for different types of cancer. Although traditional double-blind clinical trials may be difficult to apply to qigong study due to a lack of a compatible sham qigong, in reality a reasonably large sample size with a compatible control is crucial for examining such an alternative therapy.
For any scientific study of a new therapy or treatment, a large amount of time and resources are needed for an accurate account of effectiveness, dose response, and side effects. However, most studies of qigong therapy have been done by Chinese scientists who were confronted with the problems that come with a lack of support and resources. Some studies were actually conducted by qigong practitioners or amateurs, and some studies were simple minded and very preliminary due to lack of experience and/or support from health care professionals. Although well intentioned, these studies have often attracted criticism with regard to their quality and reliability.
Qigong therapy is a practice that uses qi, the vital energy of the body, to treat diseases and maintain one's health. Although the physical existence of qi is still under debate in Western medicine, like acupuncture, it is widely accepted by qigong practitioners that qi is a form of energy that circulates through the "meridian" and that any blockage of the qi flow in a particular area of the body is considered the point where the disease has originated. The qigong practitioner may use his qigong to break the qi blockage so as to relieve the pain or disease. However, the mechanism of how qi works and its interactions with the body remain mostly unknown. Although some research has explored its mechanism, there is no general consensus on qi and how qigong works, which is a major obstacle for health professionals to make use of this seemingly effective therapy.
As previously pointed out, qigong comes in many forms, and not all qigong forms are effective in treating cancer; nor can all "qigong masters" effectively emit external qi for cancer study. As reported in Zhao et al, 35 some qigong healers produced more tumor growth in the treatment group compared to the control group, possibly due to their lack of proper technique in the emission of qi. To add to this complexity, many "qigong masters" claim their form of qigong is superior to others in terms of the therapeutic effect. Without any physical or biological measurement of qi and its effects, and the lack of general interest in understanding the qigong effect from the research community, it is extremely difficult to measure effectiveness or success of one type of qigong over another. Many studies of qigong therapy for cancer did not specify what forms of qigong were used and how they differed from each other, making the reviews and evaluations even more problematic. Therefore, it is necessary to pay more attention to what type and format of qigong is used during the treatment and explore the common and/or various mechanisms for different kinds of qigong.
If one plans to conduct research on external qigong therapy for cancer, one should be prepared to experience some failures in the beginning. Not all researchers have had positive findings in their qigong explorations. First, it is hard to locate a qualified qigong healer to collaborate in research, as there are many more well-meaning but ineffective "masters" or unqualified qigong practitioners than practitioners with real and testable ability. Even if one obtains some positive findings with the right healer(s), it may not be possible to repeat the same result even with the same healer, as the results of each study are highly related to a variety of factors such as the presence of others, the environment, the healer's subjective feeling, and physical and psychological well-being. When discussing external qi therapy, we are talking about the effect of concentrating human intention and subtle energy, which may vary tremendously as different elements come into play. Many of the published studies were the result of perseverance after a number of failures or insignificant effects in the previous (unpublished) studies. We found some reports on the absence of an effect from external qigong therapy in the literature. 57 It is a great challenge to conduct high-quality research on qigong therapy, especially without support in funding and resources.
Conclusions
The very existence of human subtle energy has been a challenge for modern medicine and modern science in general, since we have no effective means to measure it and we know nothing more than simple observations of various phenomena so far. Therefore, the general tendency of the scientific community has been to ignore its existence, sometimes labeling it as placebo effect and avoiding any study of it. However, the therapeutic effect of this subtle energy on cancer may change this tendency. Much evidence suggests that qigong therapy for cancer is more than just a psychological effect. Studies on qigong and its curative effect on cancer have demonstrated consistent results for its inhibitory effect on cancer growth and metastasis in both in vitro and in vivo studies, as well as in clinical observation. It is possible to reach a general conclusion that qigong therapy for cancer treatment may be a powerful alternative to what we are using today in treating cancer.
There is much room for improvement in these studies, and some need to be replicated by more laboratories and clinics in order to verify the findings. Additionally, qigong therapy is an area that is often neglected by mainstream medicine and research. Our review suggests that this therapy be seriously examined and be considered as an important supplement to the conventional treatment of cancer and other chronic diseases.
Chinese scientists are not alone in proving the therapeutic effect of human subtle energy in cancer treatment. Fahrion and Norris, 58 Bengston and Krinsley 59 in the United States, and Sherstnev and Gruden 60 in Russia have all independently verified the inhibitory effect of human subtle energy on tumor growth. Hopefully, more scientists around the world will follow their steps and put their efforts together in this challenging area.
